Trial initiated for long-lasting injectable PrEP to block HIV transmission
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
The fact that over half of the 35 million people living with HIV in sub-Saharan…
Globally, 16 million women live with HIV, accounting for 50% of the HIV-infected adult population,…